Delivery Order SPE2DR25D1007-SPE2DR26FY8ED
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $1,626.96, represents a non-competitive, non-set-aside award with an ultimate completion date of November 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $11,089.97. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,968.48 for Dapagliflozin 10 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a specific pharmaceutical fulfillment under DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $6,100.21 and an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The order was placed to the company's place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This is a firm fixed price delivery order valued at $69,665.43 with an ultimate completion date of October 23, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,975.85 and an ultimate completion date of October 31, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dapagliflozin is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package. This order is valued at $1,825.56 with a firm fixed price structure and carries a completion date of July 30, 2025. The contract involves no set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $7,971.96. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for ultimate completion on August 27, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package, valued at $1,036.29. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,494.45 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process...
- SPE2DR25D1007Indefinite Delivery Contract
- SPE2DR25D1007-SPE2DR26FY8EDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 tablets, valued at $1,540.36. This is a firm fixed-price delivery order with an ultimate completion date of November 17, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including deliveries to the Defense Health Agency and U.S. Coast Guard. Dapagliflozin is a diabetes medication supplied as part of AmerisourceBergen's extensive portfolio of therapeutic pharmaceutical products across the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/14/25 |